Back to Agenda
Session 4: Regulatory Guidance from the FDA
Session Chair(s)
Sandeep Menon, PhD
Chief Scientific Officer of Artificial Intelligence and Digital Science and SVP,
Pfizer Inc, United States
- Well understood and less-well understood adaptive designs
- Statistical considerations for less-well understood adaptive designs
- Considerations for Adaptive Design Protocol
- Safety Considerations in Adaptive Trials
Have an account?